Neuroone Medical Dividends
| NMTC Stock | USD 1.08 0.06 5.26% |
As of January 9, 2025, Dividend Paid And Capex Coverage Ratio is expected to decline to -24.14. Neuroone Medical's past performance could be the main factor of why investors trade Neuroone Medical Technologies stock today. Investors should clearly understand every aspect of the Neuroone Medical dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Neuroone Medical's dividend schedule and payout information. Neuroone Medical Technologies dividends can also provide a clue to the current valuation of Neuroone Medical.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | (22.99) | (24.14) |
Neuroone |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Neuroone Medical must own a stock before its ex-dividend date to receive its next dividend.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share | Quarterly Revenue Growth 0.311 | Return On Assets | Return On Equity |
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.